lower gastrointestinal disease with surgical indication (regardless of benign or malignant) Lower gastrointestinal surgery, surgical site infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients scheduled for elective lower gastrointestinal surgery (regardless of open surgery or laparoscopic surgery) 2 Patients weight over 80 kg and BMI 25 kg/m2 or weight less than 40kg and BMI 18.5 kg/m2 or patients excluding weight and BMI already shown. 3 Patients over 20 years old, regardless of gender 4 Patients who can give written informed consent to participate in this study
Exclusion criteria
Exclusion criteria: 1 Patients with a history of allergies to Cefmetazole 2 Patients with a history of allergies to cephems 3 Patients who take drugs require caution in combination use 4 Patients who are pregnant or nursing 5 Patients with diseases in the brain and spinal cord 6 Patients with renal dysfunction who have creatinine clearance less than 50 ml / min estimated by Cockcroft-Gault equation (Use ideal body weight for patients weighing over 80kg) 7 Patients judged inappropriate for this study by the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pharmacokinetic parameters (Cmax, AUC, T1/2, Tmax) of drug in plasma, peritoneal fluid and abdominal tissues (peritoneum and subcutaneous adipose tissue) | — |
Contacts
Hiroshima University graduate school